Fourier transform infrared spectroscopy and metabolic profiling in lung cancer

P. Kloer, R. Ghosal, Luis Alejandro Jose Mur, K. E. Lewis, P. D. Lewis

Research output: Chapter in Book/Report/Conference proceedingConference Proceeding (Non-Journal item)

Abstract

Introduction: We have shown that sputum is a feasible biofluid for analysis of biomarkers using Fourier transform infrared (FTIR) spectroscopic analysis and that FTIR can detect different patterns of metabolites between patients with lung cancer and healthy volunteers.1 Aim: To analyse further the FTIR spectrometric patterns in more patients with lung cancer and also smokers deemed 'high risk'. To identify what actual compounds may differentiate cancer from non-cancer sputum samples. Methods: Loco-regional ethical permission was obtained.
Original languageEnglish
Title of host publicationWinter Meeting of the British-Thoracic-Society
PagesA60-A61
Publication statusPublished - 01 Dec 2008
EventWinter Meeting of the British-Thoracic-Society - London, United Kingdom of Great Britain and Northern Ireland
Duration: 03 Dec 200805 Dec 2008

Conference

ConferenceWinter Meeting of the British-Thoracic-Society
Country/TerritoryUnited Kingdom of Great Britain and Northern Ireland
CityLondon
Period03 Dec 200805 Dec 2008

Fingerprint

Dive into the research topics of 'Fourier transform infrared spectroscopy and metabolic profiling in lung cancer'. Together they form a unique fingerprint.

Cite this